Traditional Chinese Herbal Medicine for Allergic Diseases: A Review.

Allergic Diseases Axis Balance Chinese Patent Medicine (CPM) Inflammation Oxidative Stress Signaling Pathway Traditional Chinese Herbal Medicine (TCHM)

Journal

The American journal of Chinese medicine
ISSN: 1793-6853
Titre abrégé: Am J Chin Med
Pays: Singapore
ID NLM: 7901431

Informations de publication

Date de publication:
2023
Historique:
medline: 19 6 2023
pubmed: 16 4 2023
entrez: 15 4 2023
Statut: ppublish

Résumé

The prevalence of allergic disorders has increased in recent years, lowering patients' quality of life and increasing the demand for drugs to treat these diseases. Western drugs such as glucocorticoids, antihistamines, and leukotrienes are routinely utilized in clinics. However, drawbacks like high recurrence rates and adverse effects limit their use. As one of the most promising natural medicine systems, traditional Chinese medicine offers distinct benefits in treating allergic illnesses, such as maintaining long-term treatment, preventing disease recurrence, and producing fewer adverse reactions. We analyzed and discussed recent developments in traditional Chinese medicine used in allergic diseases from three perspectives: Chinese herbal formula, Chinese patent medicine, and active ingredients of traditional Chinese medicine, and explained their main components, efficacy, and mechanisms of action. We also reviewed the modification of Chinese herbal formulas and the combined application of Chinese medicine with Western medicine or nonpharmaceutical therapies. Traditional Chinese medicines are becoming increasingly important in treating allergic disorders. Improving traditional Chinese herbal formulas and developing safe and effective Chinese patent medicines are currently the most pressing and important aspects of research on traditional Chinese medicine.

Identifiants

pubmed: 37060193
doi: 10.1142/S0192415X23500374
doi:

Substances chimiques

Drugs, Chinese Herbal 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

779-806

Auteurs

Chenyang Ai (C)

Institute of Pharmaceutical Innovation, Hubei Province Key Laboratory of Occupational, Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei 430065, P. R. China.

Yi Zou (Y)

Institute of Pharmaceutical Innovation, Hubei Province Key Laboratory of Occupational, Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei 430065, P. R. China.

Hao Liu (H)

Institute of Pharmaceutical Innovation, Hubei Province Key Laboratory of Occupational, Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei 430065, P. R. China.

Zheqiong Yang (Z)

Demonstration Center for Experimental Basic Medicine Education, Wuhan University TaiKang Medical School, (School of Basic Medical Sciences), Wuhan, Hubei 430071, P. R. China.

Jinlei Xi (J)

Institute of Pharmaceutical Innovation, Hubei Province Key Laboratory of Occupational, Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei 430065, P. R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH